Drug Topics
AUGUST 21, 2023
Receiving the vaccine during pregnancy is cited as crucial for both confronting disproportionate infant vulnerability and easing the disease burden for new and expecting mothers.
Pharmacy Times
AUGUST 21, 2023
“I've never met a pharmacist who didn't want to improve the health of the American people. That's what they're doing and will be doing well in the future,” Steven C. Anderson tells Pharmacy Times at NACDS TSE, August 12 through 14, 2023, San Diego, California.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
AUGUST 21, 2023
A recent study found that Infants younger than 3 months, those born prematurely, and those who were publicly insured were at a higher risk for intubation.
Pharmacy Times
AUGUST 21, 2023
The results differ from previous studies and the predictions of the researchers that the Child Tax Credit would reduce the prevalence of low birth weight among pregnant women across the country.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
AUGUST 21, 2023
Maternal outcomes and disparities may be improved through postpartum navigation, in which a mother works with their provider to navigate barriers to care.
Pharmacy Times
AUGUST 21, 2023
The model was the first to incorporate C-reactive protein/albumin ratio and apply LASSO regression analysis to a predictive model for children with Kawasaki disease.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
AUGUST 21, 2023
Throughout RBC 2023, Cardinal Health leaders recognized the role of retail independent pharmacies as cornerstones in their communities, delivering personalized care with passion and dedication to the families they serve.
STAT
AUGUST 21, 2023
The Food and Drug Administration on Monday approved a Pfizer vaccine that aims to protect newborns against RSV by vaccinating pregnant people in the latter part of pregnancy. The vaccine, Abrysvo, has also been approved for use in adults 60 and older to protect them against respiratory syncytial virus.
Pharmacy Times
AUGUST 21, 2023
Most participants who received retatrutide lost a considerable amount of body weight; however, individual results varied given the diversity of obesity.
Fierce Pharma
AUGUST 21, 2023
Regeneron pulled off a rare double play on Friday afternoon as it scored two FDA approvals—one under the radar and the other highly anticipated. | With the FDA signing off on Regeneron and Bayer’s high-dose Eylea, the companies are set to take on Roche’s Vabysmo in a high-stakes battle for the massive eye disease market.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
AUGUST 21, 2023
MEXICO CITY — Kellogg’s is waging a war here over Tigre Toño and Sam el Tucán. A 2019 policy requires companies that make unhealthy foods to include warning labels on the front of any boxes they sell in Mexico to educate consumers about things like excess sugar and fat. Any food with a warning label — like Kellogg’s Fruit Loops or its Frosted Flakes, which typically contain more than 37 grams of added sugar in a 100-gram serving — is also banned from
The Checkup by Singlecare
AUGUST 21, 2023
You might feel lightheaded or off-balance when you get overheated or dehydrated. Perhaps you even get dizzy. Vertigo, in particular, is dizziness that causes a feeling of movement when a person is not moving. Almost 40% of Americans experience vertigo at least once in their lifetime. Some people experience vertigo—a nausea-inducing tilting or spinning sensation—even when well-rested and hydrated.
Fierce Pharma
AUGUST 21, 2023
First came doubts about the combinability of Amgen’s Lumakras with a standard PD-1 inhibitor. | The FDA will hold an advisory committee meeting to discuss confirmatory trial data for Amgen's Lumakras in KRAS-mutated lung cancer. This comes after a bumpy stretch for the medicine since its debut in 2021.
Fierce Healthcare
AUGUST 21, 2023
The nation’s leading lobbying group for older Americans is supporting the U.S. | In a federal lawsuit, AARP is supporting Medicare’s new ability to negotiate drug prices with pharmaceutical companies, ahead of CMS naming the first 10 prescription drugs next month.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
AUGUST 21, 2023
Earlier this month, Intellia Therapeutics announced it was scrapping plans to include U.S.-based sites in one of its mid-stage CRISPR trials after the Food and Drug Administration requested additional data to support including female patients of childbearing potential. The move left many researchers wondering whether the specter of accidental germline transmission — which haunted early gene therapy trials — had now risen over the field of gene editing.
Digital Pharmacist
AUGUST 21, 2023
As we gear up for the upcoming flu season of 2023-2024, it’s important to reflect on the lessons of the previous year , and understand how the coming year may look different. In this article, we’ll delve into a comprehensive breakdown of the past season’s dynamics and provide valuable insights to equip you for the challenges and opportunities that lie ahead.
Fierce Pharma
AUGUST 21, 2023
After a losing streak in the clinic, Roche and Exelixis’ combo of Tecentriq and Cabometyx has delivered a trial win in tough-to-treat prostate cancer. | Roche’s immuno-oncology star Tecentriq plus Exelixis and Ipsen’s tyrosine kinase inhibitor Cabometyx helped patients with pretreated metastatic castration-resistant prostate cancer live longer without their disease getting worse, the partners said Monday.
STAT
AUGUST 21, 2023
As a health care economist who studies innovation, and as a management consultant who helps health systems and insurers adopt new technologies, we have had a ringside seat to a frustrating phenomenon: The large private sector of the U.S. health system can move faster to adopt valuable innovations than the public sector burdened by red tape and politics.
Fierce Pharma
AUGUST 21, 2023
The Justice Department has gained a new ally in its quest to knock down a lawsuit from the U.S. Chamber of Commerce challenging “illegal price controls” in the Inflation Reduction Act (IRA). | The Justice Department has gained a new ally in its quest to knock down a lawsuit from the U.S. Chamber of Commerce challenging “illegal price controls” in the Inflation Reduction Act (IRA).
Drug Topics
AUGUST 21, 2023
Investigators said the findings show how efforts to encourage more people to get recommended cancer checks are crucial.
Fierce Healthcare
AUGUST 21, 2023
The Minnesota Attorney General's office is investigating Allina Health over reports that the provider restricted care to patients with certain amounts of unpaid medical bills. | The Minnesota Attorney General's office is investigating Allina Health over reports that the provider restricted care to patients with certain amounts of unpaid medical bills.
STAT
AUGUST 21, 2023
Good morning, everyone. Damian Garde here, filling in for Ed Silverman on yet another dog day of what has been a particularly canine summer. So begins another working week for those of us unlucky, unwise, or un-European enough to not be on a beach someplace. Here as always are a few items to get your day started. And if you hear anything curious out there, do let us know.
PharmExec
AUGUST 21, 2023
In this exclusive Q&A with Pharmaceutical Executive, Janice Chang, CEO of TransCelerate BioPharma, provides an inside look into her career journey, her work at the company, how the industry has changed in the last 10 years, as well as her thoughts on where the industry should put its efforts in clinical trials.
STAT
AUGUST 21, 2023
To much of the public, the promise of telehealth is all about convenience — get the prescription you need quickly, and get it delivered right to your door. But as digital health companies build out their weight loss businesses, capitalizing on the popularity of drugs like Wegovy and Ozempic, they’re courting a very different audience: payers and employers who have a vested interest in preventing quick scripts.
Fierce Healthcare
AUGUST 21, 2023
CVS Health announced earlier this year that it would cut 5 | CVS Health announced earlier this year that it would cut 5,000 corporate jobs in a bid to cut costs, and new filings across several states offer a look at where those cuts are taking place.
European Pharmaceutical Review
AUGUST 21, 2023
According to a market report , the global RNA therapy clinical trials market is anticipated to reach $3.5 billion by 2030 and grow at a CAGR of 3.84 percent from 2023 to 2030. The data stated that expansion of the market in emerging countries is due to factors such as the rising success rate of RNA-based COVID-19 vaccines, regulatory approval, as well as demand for personalised medicines.
Drug Store News
AUGUST 21, 2023
Forget The Filler Skin-Plumping Line-Smoothing Perfecting Cream is a deep treatment and priming moisturizer designed to perfect the look of skin, the brand said.
European Pharmaceutical Review
AUGUST 21, 2023
For 20 of the leading biopharmaceutical companies, the second quarter (Q2) of 2023 has brought an aggregate market capitalisation growth of 2.3 percent. Data and analytics company GlobalData has reported a rise from $3.49 trillion in the Q1 of 2023 to $3.56 trillion in Q2 2023. Q2 2023 biopharma market capitalisation results Eli Lilly “Eli Lilly witnessed the largest market capitalisation growth of 36.1 percent over Q2 2023, moving up to first position in the list and displacing Johnson & Jo
Pharmacy Times
AUGUST 21, 2023
The treatment is the first of its kind to be FDA-approved to treat CHAPLE disease.
Pharmaceutical Technology
AUGUST 21, 2023
The EC approved Janssen's Type II variation application for reduced dosing frequency of bispecific antibody TECVAYLI for multiple myeloma.
Drug Store News
AUGUST 21, 2023
Walmart has completed renovations on a supercenter at 400 Park Place in Secaucus, N.J., marking the occasion with a ribbon-cutting ceremony.
PharmaVoice
AUGUST 21, 2023
The depression space recently got a stinging FDA rebuke — but Brii thinks it can break through with improved formulations.
Drug Store News
AUGUST 21, 2023
The powder meal topper contains a probiotic designed to help maintain a natural balance within a dog’s digestive system, the company said.
Pharmaceutical Technology
AUGUST 21, 2023
The US Food and Drug Administration (FDA) has granted approval to Regeneron Pharmaceuticals’ EYLEA HD injection 8 mg.
Expert insights. Personalized for you.
186 
Let's personalize your content